Entity Common Stock, Shares Outstanding of Oruka Therapeutics, Inc. from 11 Aug 2011 to 31 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Oruka Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 11 Aug 2011 to 31 Oct 2025.
  • Oruka Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 31 Oct 2025 was 48,409,232, a 38% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Oruka Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 48,409,232 +13,410,682 +38% 31 Oct 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 37,450,745 +22,943,602 +158% 31 Jul 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 37,440,510 +22,933,367 +158% 30 Apr 2025 10-Q 14 May 2025 2025 Q1
Q3 2024 34,998,550 +20,588,407 +143% 31 Oct 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 14,507,143 +97,000 +0.67% 31 Jul 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 14,507,143 +97,000 +0.67% 24 Apr 2024 10-Q 25 Apr 2024 2024 Q1
Q4 2023 14,501,143 31 Jan 2024 10-K 01 Feb 2024 2023 FY
Q3 2023 14,410,143 0 0% 17 Oct 2023 10-Q 18 Oct 2023 2023 Q3
Q2 2023 14,410,143 0 0% 20 Jul 2023 10-Q 21 Jul 2023 2023 Q1
Q1 2023 14,410,143 0 0% 24 Apr 2023 10-Q 24 Apr 2023 2023 Q1
Q3 2022 14,410,143 0 0% 27 Oct 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 14,410,143 0 0% 01 Aug 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 14,410,143 0 0% 11 Mar 2022 10-K 14 Mar 2022 2021 FY
Q3 2021 14,410,143 +5,088,673 +55% 01 Nov 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 14,410,143 +8,504,859 +144% 03 Aug 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 14,410,143 +12,816,073 +804% 16 Mar 2021 10-K 18 Mar 2021 2020 FY
Q3 2020 9,321,470 +7,727,400 +485% 30 Oct 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 5,905,284 +4,449,728 +306% 31 Jul 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 1,594,070 +495,257 +45% 05 May 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 1,594,070 13 Feb 2020 10-K 18 Feb 2020 2019 FY
Q3 2019 1,594,070 -12,329,988 -89% 01 Nov 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 1,455,556 -12,468,269 -90% 31 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 1,098,813 -12,815,507 -92% 06 May 2019 10-Q 08 May 2019 2019 Q1
Q3 2018 13,924,058 +2,173,081 +18% 12 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 13,923,825 +2,173,081 +18% 07 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 13,914,320 +4,783,394 +52% 19 Mar 2018 10-K 22 Mar 2018 2017 FY
Q3 2017 11,750,977 +2,668,611 +29% 07 Nov 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 11,750,744 +2,684,396 +30% 31 Jul 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 9,130,926 +74,279 +0.82% 17 Mar 2017 10-K 21 Mar 2017 2016 FY
Q3 2016 9,082,366 +31,149 +0.34% 10 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 9,066,348 -54,153,642 -86% 05 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 9,056,647 -12,141,764 -57% 15 Mar 2016 10-K 17 Mar 2016 2015 FY
Q3 2015 9,051,217 -12,099,269 -57% 10 Nov 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 63,219,990 +42,209,175 +201% 07 Aug 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 21,198,411 +218,571 +1% 17 Mar 2015 10-K 19 Mar 2015 2014 FY
Q3 2014 21,150,486 +5,474,924 +35% 10 Nov 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 21,010,815 +10,060,053 +92% 12 Aug 2014 10-Q 13 Aug 2014 2014 Q2
Q1 2014 20,979,840 +17,794,278 +559% 17 Mar 2014 10-K 20 Mar 2014 2013 FY
Q3 2013 15,675,562 +230,780 +1.5% 08 Nov 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 10,950,762 -3,668,836 -25% 09 Aug 2013 10-Q 13 Aug 2013 2013 Q2
Q1 2013 3,185,562 -8,997,437 -74% 18 Mar 2013 10-K 21 Mar 2013 2012 FY
Q3 2012 15,444,782 +4,928,449 +47% 09 Nov 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 14,619,598 +4,103,265 +39% 10 Aug 2012 10-Q 13 Aug 2012 2012 Q2
Q1 2012 12,182,999 23 Mar 2012 10-K 27 Mar 2012 2011 FY
Q3 2011 10,516,333 09 Nov 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 10,516,333 11 Aug 2011 10-Q 15 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.